May 24, 2022 / 08:00PM GMT
Presentation at Digestive Disease Week Call
May 24, 2022 / 08:00PM GMT
=====================
Corporate Participants
=====================
* Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer
* Michael Corbo
Pfizer Inc. - Chief Development Officer, Inflammation & Immunology
* Michael S. Vincent
Pfizer Inc. - Senior VP and Chief Scientific Officer, Inflammation & Immunology
* Mike Gladstone
Pfizer Inc. - Global President, Inflammation & Immunology
* Sheldon Sloan
Arena Pharmaceuticals Inc. - Vice President, Etrasimod UC Team Lead
=====================
Conference Call Participants
=====================
* Brian Tsang
Wolfe Research, LLC - Research Analyst
* Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
* Evan David Seigerman
BMO Capital Markets Equity Research - MD & Senior BioPharma Research Analyst
* Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Pfizer Inc
(MIL:1PFE)
€
24.625
-0.215 (-0.87%)
Market Cap: 139.23 Bil
Enterprise Value: 192.39 Bil
PE Ratio: 35.39
PB Ratio: 1.61
GF Score: 64/100 Pfizer Inc Analyst and Investor Call to Discuss Etrasimod Data Presentation at Digestive Disease Week Call Transcript
May 24, 2022 / 08:00PM GMT
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot